The effect of laminins on chemoresistance of colorectal cancer cells


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Earlier, the data on the ability of laminin-332 to protect liver cancer cells from apoptosis caused by doxorubicin, sorafenib, and gefitinib have been obtained. In order to answer the question whether this action of laminins is common for cancer cells of other types, we estimated the effect of several laminin isoforms on the survival of two colorectal cancer cell lines (RKO and SW-480) when treated with chemotherapeutic agents used in the colon cancer therapy (5-fluorouracil, regorafenib, and sorafenib). The data obtained suggest that this action of laminins is not universal and is likely governed by individual features of cancer cells.

作者简介

D. Maltseva

Scientific Research Center Bioclinicum; National Medical Research Radiology Center, Ministry of Health of the Russian Federation

编辑信件的主要联系方式.
Email: dmaltseva@gmail.com
俄罗斯联邦, 85 Build., 2 ul. Ugreshskaya, Moscow, 115088; 4 ul. Koroleva, Obninsk, 249036

G. Zakharova

Scientific Research Center Bioclinicum

Email: dmaltseva@gmail.com
俄罗斯联邦, 85 Build., 2 ul. Ugreshskaya, Moscow, 115088

S. Rodin

Scientific Research Center Bioclinicum; Department of Medical Biochemistry and Biophysics, Karolinska Institutet

Email: dmaltseva@gmail.com
俄罗斯联邦, 85 Build., 2 ul. Ugreshskaya, Moscow, 115088; Stockholm, 17177

A. Tonevitsky

Scientific Research Center Bioclinicum

Email: dmaltseva@gmail.com
俄罗斯联邦, 85 Build., 2 ul. Ugreshskaya, Moscow, 115088

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2018